Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Farid Adrienne. Insider active across 1 company, notably Century Therapeutics, Inc.. In total, 12 filings have been published. Breakdown: 0 buy · 8 sells. Total volume traded: €16k. History available since 2 February 2023. The latest transaction was disclosed on 9 June 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Farid Adrienne
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
552 shares@ US$0.6220.7% of flowCommon StockSEC:0001062993-25-011428:0
1,024 shares@ US$0.551.1% of flowCommon StockSEC:0001062993-25-008775:0
2,359 shares@ US$0.6153.0% of flowCommon StockSEC:0001062993-25-005289:0
1,054 shares@ US$0.781.8% of flowCommon StockSEC:0001062993-25-001756:0
1,033 shares@ US$1.2272.6% of flowCommon StockSEC:0001062993-24-018339:0
1,073 shares@ US$1.8274.0% of flowCommon StockSEC:0001062993-24-014585:0
913 shares@ US$3.1065.9% of flowCommon StockSEC:0001062993-24-009573:0
24,000 shares0Common StockSEC:0001062993-24-006182:0
30,684 shares@ US$1.0364.6% of flowCommon StockSEC:0001062993-24-006058:0
485 shares@ US$1.031.0% of flowCommon StockSEC:0001062993-24-003878:0
2,035 shares@ US$3.84116.1% of flowCommon StockSEC:0001062993-24-002320:0
21,875 shares0Common StockSEC:0001062993-23-002308:0
About Farid Adrienne
Farid Adrienne is Chief Operations Officer at Century Therapeutics, Inc. (XNAS). She has 12 filings in total, and across the sampled recent filings from 2023-02-06 to 2025-06-11, the transactions show EUR 0 of buys and EUR 15,785 of sells, with the transaction nature indicated as Cession.